We’re disappointed that Biogen AND Eisai have stopped two phase III trials of Alzheimer’s drug aducanumab. But we’re encouraged by the growing number of new avenues being explored by researchers across the world. Their work has never been more important.
Today we’re launching our Dementia Attitudes Monitor Report – an in-depth analysis ...Read more
In the three years since we launched our Manifesto 2015-2020, which outlined ...Read more
In 2008 at the age of 58 I made a big change ...Read more
It can come as a surprise to know that having Down’s syndrome puts people at much higher risk of Alzheimer’s. In fact, the genetic rearrangement that causes Down’s syndrome is one of the greatest genetic risk factors for Alzheimer’s. Sadly, everyone with Down’s syndrome will have developed the characteristic plaques and tangles of Alzheimer’s in […]
It’s a year today since Alzheimer’s Research UK launched the Dementia Access Taskforce. The first-of-its-kind partnership brings together charities, researchers, pharmaceutical companies, government and people impacted by dementia. The group works to ensure early and accurate diagnosis is available and to prepare so future treatments reach people quickly. Last year, we looked at the challenges […]
There’s just one week left to support our petition to ask government to fund more research than ever before. More than half of us have a close friend or family member with dementia, and with no treatments to stop or cure the diseases that cause it, no-one has yet survived. But breakthroughs in dementia research […]
The years after my husband’s vascular dementia diagnosis were very difficult for us both. But as time has gone on I have found several things that have improved matters, both for him and for me as his partner. I would like to share some of my tips, in the hope that, although they are very much simply my personal rules for coping with my own situation, others may also find some of them useful.